stictic acid has been researched along with 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
| Amaro, RE; Baronio, R; Chen, CK; Chung, BP; Demir, Ö; Hall, LV; Hatfield, GW; Kaiser, P; Lathrop, RH; Lin, DW; Luecke, H; Richard Chamberlin, A; Salehi, F; Wallentine, BD; Wassman, CD | 1 |
| Omar, SI; Tuszynski, J | 1 |
3 other study(ies) available for stictic acid and 2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one
| Article | Year |
|---|---|
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |
Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53.
Topics: Apoptosis Regulatory Proteins; Aza Compounds; Binding Sites; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Computational Biology; Cyclin-Dependent Kinase Inhibitor p21; Cysteine; Heterocyclic Compounds, 4 or More Rings; Humans; Molecular Dynamics Simulation; Mutant Proteins; Oxepins; Protein Stability; Protein Structure, Secondary; Protein Structure, Tertiary; Proto-Oncogene Proteins; Reproducibility of Results; Structure-Activity Relationship; Transcription, Genetic; Tumor Suppressor Protein p53 | 2013 |
Ranking the Binding Energies of p53 Mutant Activators and Their ADMET Properties.
Topics: Alkylation; Amifostine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Drug Evaluation, Preclinical; Ellipticines; Heterocyclic Compounds, 4 or More Rings; Humans; Kinetics; Ligands; Mercaptoethylamines; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Mutation; Oxepins; Protein Binding; Pyrimidines; Quinuclidines; Tumor Suppressor Protein p53 | 2015 |